» Articles » PMID: 37545115

Autonomic Dysreflexia: Current Pharmacologic Management

Overview
Journal PM R
Publisher Wiley
Date 2023 Aug 7
PMID 37545115
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Autonomic dysreflexia (AD) is a frequent complication of spinal cord injury (SCI), though current clinical practice patterns for medication management of this condition are unknown. Correspondingly, it is unclear if national differences in practice patterns exist.

Objective: To determine trends in current pharmacologic management of AD throughout the Americas.

Design: International survey of current physician practice patterns.

Setting: Academic medical center.

Participants: Sixty physicians managing patients with SCI and prescribing medications to manage AD.

Interventions: Not applicable.

Main Outcome Measures: Presence of a formal pharmacologic AD management protocol, first- and second-line medications, patient characteristics influencing pharmacologic management.

Results: The majority of physicians (69%) had a formal AD management protocol for inpatient care, with nitroglycerin ointment (82%) being the most common first-line medication. Strong national differences existed regarding the use of nitroglycerin ointment, with 98% of U.S.-based physicians using this as first-line medication and 0% of physicians in Canada or Latin America using this due to recent lack of medication availability. Only 67% of physicians had a preferred second-line medication, with preferences split between hydralazine (48%) and nifedipine (28%). A systolic blood pressure threshold for pharmacologic management was used by 56% of physicians, wheres 26% considered neurological level of injury in decisions to use medications for AD. Heart rate was used by only 5% of physicians in their decision to manage AD with medications.

Conclusions: As of 2023, U.S.-based physicians caring for individuals with SCI largely have formal inpatient protocols in place for medication management of AD, with nearly all relying on nitroglycerin ointment as their first-line medication. In areas outside of the United States where nitroglycerin ointment is unavailable, pharmacologic practice patterns significantly differ.

Citing Articles

Autonomic dysreflexia with relative tachycardia: Potential physiologic pathways for this head scratching clinical finding.

Solinsky R, Singer W PM R. 2024; 17(1):54-58.

PMID: 39126312 PMC: 11735299. DOI: 10.1002/pmrj.13247.


Characterizing preserved autonomic regulation following spinal cord injury: Methods of a novel concerted testing battery and illustrative examples of a new translationally focused data representation.

Solinsky R, Burns K, Hamner J, Singer W, Taylor J medRxiv. 2024; .

PMID: 38854077 PMC: 11160853. DOI: 10.1101/2024.05.31.24308290.


Why do different people with Spinal Cord Injury have differing severity of symptoms with Autonomic Dysreflexia? Exploring relationships of vascular alpha-1 adrenoreceptor and baroreflex sensitivity after SCI.

Dens Higano J, Burns K, Smith G, Solinsky R medRxiv. 2024; .

PMID: 38746296 PMC: 11092739. DOI: 10.1101/2024.05.02.24306772.


Autonomic impairment is not explained by neurological level of injury or motor-sensory completeness.

Burns K, Solinsky R Spinal Cord. 2024; 62(7):367-370.

PMID: 38609568 PMC: 11230852. DOI: 10.1038/s41393-024-00994-7.

References
1.
. Acute management of autonomic dysreflexia: adults with spinal cord injury presenting to health-care facilities. Consortium for spinal cord. J Spinal Cord Med. 1997; 20(3):284-308. DOI: 10.1080/10790268.1997.11719480. View

2.
. Acute management of autonomic dysreflexia: individuals with spinal cord injury presenting to health-care facilities. J Spinal Cord Med. 2002; 25 Suppl 1:S67-88. View

3.
Dolinak D, Balraj E . Autonomic dysreflexia and sudden death in people with traumatic spinal cord injury. Am J Forensic Med Pathol. 2007; 28(2):95-8. DOI: 10.1097/PAF.0b013e3180600f99. View

4.
Reitz A, Knapp P, Muntener M, Schurch B . Oral nitric oxide donors: a new pharmacological approach to detrusor-sphincter dyssynergia in spinal cord injured patients?. Eur Urol. 2004; 45(4):516-20. DOI: 10.1016/j.eururo.2003.11.006. View

5.
Solinsky R, Bunnell A, Linsenmeyer T, Svircev J, Engle A, Burns S . Pharmacodynamics and effectiveness of topical nitroglycerin at lowering blood pressure during autonomic dysreflexia. Spinal Cord. 2017; 55(10):911-914. DOI: 10.1038/sc.2017.58. View